The BRA had discussed the project at its previous meeting, but according to BRA spokesperson Meredith Baumann, it was tabled because there were concerns about the height of the building. As originally proposed, the facility was to be 18 stories high and 440,000 sf. Baumann tells GlobeSt.com that because the project was proposed while the BRA is in the process of developing its Longwood Medical Area interim guidelines it is unclear if that density and height would ultimately be acceptable.

Baumann says that the BRA decided to approve the project at 16 stories and 352,000 sf with the caveat that as the LMA strategic plan moves forward the BRA may revisit the plan and approve the project at its full build out. "We are allowing for the possibility that the strategic plan may allow for higher stories," says Baumann." It may be okay to build at that density but we don't want to hold them up. They'll be able to incorporate [the addition]." She notes that the guidelines address the need for institutions to grow in the LMA while ensuring that it is an area where people can live and businesses function.

The project is being developed by Lyme Properties through a joint planning effort with Beth Israel, which owns the site. The plan still needs approval from the city's zoning commission. Lyme also developed the 575,000-sf Blackfan Research Center, which is next to this location.